Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost-utility analysis of Ruconest(®) (conestat alfa) compared to Berinert(®) P (human C1 esterase inhibitor) in the treatment of acute, life-threatening angioedema attacks in patients with hereditary angioedema.
Kawalec P, Holko P, Paszulewicz A. Kawalec P, et al. Among authors: paszulewicz a. Postepy Dermatol Alergol. 2013 Jun;30(3):152-8. doi: 10.5114/pdia.2013.35616. Epub 2013 Jun 20. Postepy Dermatol Alergol. 2013. PMID: 24278067 Free PMC article.
[Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review results].
Kawalec P, Holko P, Paszulewicz A, Obtułowicz K. Kawalec P, et al. Among authors: paszulewicz a. Pneumonol Alergol Pol. 2013;81(2):95-104. Pneumonol Alergol Pol. 2013. PMID: 23420425 Free article. Review. Polish.
[The evaluation of cost-effectiveness and cost-utility of valganciclovir for the prophylaxis of cytomegalovirus disease to 200 days after kidney transplantation].
Kawalec P, Holko P, Szkultecka-Debek M, Paszulewicz A, Boratyńska M, Głyda M, Ignacak E, Maks J, Russel-Szymczyk M, Kaweczyńska-Lasoń A. Kawalec P, et al. Among authors: paszulewicz a. Pol Merkur Lekarski. 2013 Jun;34(204):332-8. Pol Merkur Lekarski. 2013. PMID: 23882930 Clinical Trial. Polish.